The Global Pet Obesity Initiative Position Statement

In 2018, APOP created the Global Pet Obesity Initiative (GPOI) to create a universal set of pet obesity definitions and assessment standards. These guidelines have been formally accepted by 25 of the world’s leading veterinary medical organizations.

The Global Pet Obesity Initiative:

1) Creates a uniform definition of pet obesity.

2) Standardizes the body condition score (BCS) for dogs and cats.

3) Declares pet obesity as a disease.

Ernest E. Ward, Jr. DVM, CVFT

Alexander J. German BVSc, Ph.D., Cert SAM, DECVIM, SFHEA, FRVCS

Julie A. Churchill DVM, Ph.D., DACVN

CLICK HERE FOR PDF VERSION OF THE GPOI POSITION STATEMENT

The Global Pet Obesity Initiation Position Statement is supported by the following veterinary healthcare professional organizations:

October 13, 2019

AAFP American Association of Feline Practitioners

AAVN American Academy of Veterinary Nutrition

ACVIM American College of Veterinary Internal Medicine

ACVSMR American College of Veterinary Sports Medicine and Rehabilitation

AVNT Academy of Veterinary Nutrition Technicians

AVMA American Veterinary Medical Association- Board of Directors

BSAVA British Small Animal Veterinary Association

CVMA Canadian Veterinary Medical Association

CAVN Canadian Academy of Veterinary Nutrition

Cats Protection (U.K.)

Dogs Trust (U.K.)

ECVCN European College of Veterinary and Comparative Nutrition

ESVCN European Society of Veterinary and Comparative Nutrition

ESVE European Society of Veterinary Endocrinology

ESVIM European Society of Veterinary Internal Medicine

FECAVA Federation of European Companion Animal Veterinary Associations

ICC International Cat Care

IPFD International Partnership for Dogs

ISFM International Society of Feline Medicine

NAVTA National Association of Veterinary Technicians in America

PNA Pet Nutrition Alliance

PDSA The People’s Dispensary for Sick Animals

SCE Society for Comparative Endocrinology

WSAVA World Small Animal Veterinary Association

1. Uniform Definition of Obesity

We call for the veterinary profession to adopt uniform nomenclature for canine and feline obesity.  

There is currently no universally-accepted definition of obesity in dogs and cats, and this lack of professional consensus has created confusion among veterinary professionals, industry stakeholders, and owners.  This makes it challenging for veterinarians to provide clear messages to their clients about obesity and might explain why veterinarians rarely record the presence of obesity in the clinical records of their patients.1  We believe that adopting and widely publicizing a standard definition of obesity will raise awareness of the disease, and increase discussion and motivation to act within the profession with the ultimate goal of improving the health of cats and dogs.

Our recommendation is that the term obesity be defined as 30% above ideal body weight.  While excess body weight (overweight and obesity) represents a continuum and any cut-point for the onset of disease is somewhat arbitrary (see below), this definition correlates with the determination of obesity in humans using the standard metric such as body mass index (BMI) and abdominal circumference.2  It is also consistent and broadly supported by veterinary studies where there are associations with various comorbid diseases,3-5 functional impairment,6-11, and decreased quality of life.12,13  

The most practical clinical measure of adiposity is body condition score (BCS, see below), and 30% above ideal weight is equivalent to 8/9 using the preferred 9-point system.14-17  However, defining obesity on the basis of ‘above ideal weight’, rather than on the basis of condition score, is preferable because it enables veterinarians to use other strategies to identify the onset of obesity precisely in addition to the definition by BCS.  For example, if a veterinary practice recommends routine body weight and BCS assessment throughout life, and practices formally identify and record the ‘healthy adult weight’ of a dog or cat (i.e. an early-adult-life bodyweight where BCS is ideal),18 weight gain could then be accurately quantified as a percentage change from the healthy adult weight, enabling the onset of obesity to be accurately determined.

2. Universal Body Condition Score System

We urge the global veterinary community to adopt a universal Body Condition Score for dogs and cats of a whole-integer, one-through-nine (1–9) scale.  

Many different body condition scoring systems have been suggested for estimating the adiposity of dogs and cats 3,4,14-17,19-22 and, while they may be broadly comparable (for example a 5-unit system using half units is broadly equivalent to a 9-unit system), having different methods creates confusion.  Not only is this problematic for veterinary professionals and owners when discussing obesity and health care recommendations, but it can also lead to inconsistency in interpreting the results of scientific studies. 

In adopting a universal system, we believe that the 9-unit body condition score is preferable.  This system has been more extensively validated than other systems, for example by comparing scores against precise measures of body fat mass using dual-energy X-ray absorptiometry, DEXA).14-17,22  It is also the system that has been recommended by the WSAVA Global Nutrition Panel.23  We recognize that other validated methods of determining adiposity have been developed for cats and dogs, such as using multiple zoometric measures.20,21  While we would not discourage their use, we believe that body condition scoring has many advantages most notably speed and simplicity, to ensure consistent use in veterinary practices.  By adopting a universal BCS, we believe veterinary teams will be better able to interpret veterinary medical research, more consistently and accurately assess their patients’ body condition, and clearly communicate with colleagues and clients.

3. Defining Obesity as a Disease

We call for the veterinary profession formally to recognize canine and feline obesity as a disease. 

For many years, the medical profession has debated the various reasons for and against defining human obesity as a disease. 24-28 Opponents have argued that body fat gain is simply a normal physiological response to an abnormal (‘obesogenic’) environment.27,28 However, obesity develops in a pattern expected for any disease process in that one or more causal factors trigger various pathophysiological mechanisms, which ultimately lead to functional impairment.26  With obesity, the prolonged positive energy balance leads to the expansion of adipose tissue and fat deposition in other organs; this in turn promotes dysregulation of metabolic, hormonal, and/or inflammatory processes,  ultimately leading to functional impairment, comorbidities of obesity, and reduced quality of life. 

Obesity also meets the American Medical Association (AMA) definition of disease namely:

1.     An impairment of the normal functioning of some aspect of the body

2.     Demonstrates characteristic signs or symptoms

3.     Causes harm or morbidity

The final arguments against classifying obesity as a disease are that the label would negatively impact well-being and would not improve medical support for affected individuals.27,28  However, such arguments have been refuted by others who believe a formal obesity classification will actually reduce stigma and, in turn, improve access to medical care.25,26  While a clear consensus has not yet been reached, the broad trend has been toward adopting a formal disease definition.  This has been the position of the AMA since 2013,25 and is now held by many other national medical organizations, including the World Health Organization, World Obesity Federation, Food and Drug Administration, and the National Institute of Health.26,30,31

Obesity is now a major health concern worldwide with published studies suggesting that up to 59% of dogs and cats are overweight,3,4,32 making obesity one of the most common medical disorders identified in veterinary practice.5,34  Recent evidence suggests a rapidly increasing prevalence 35 and the fact that it is now a worldwide problem including in developing countries.36  Particularly concerning is the current prevalence of obesity in growing animals, whereby approximately 21% of dogs are already overweight by 6 months of age.37  Obesity can reduce life expectancy,38 negatively impact quality of life,12,13 and is associated with various comorbidities.3,4, Obesity contributes to metabolic derangements,9-11,39 significant functional impairment (most notably respiratory, cardiovascular, and renal function)10,11 and is a significant financial burden on owners.40  Thus, as with the condition in humans, the wealth of scientific data in cats and dogs supports the formal classification of obesity as a disease, and this is consistent with a position statement articulated by a group of international experts convened by the WSAVA One Health Committee.41  Obesity is further complicated by the fact that companion animals are unable to make diet and feeding choices, eliminating the complicating factor of personal accountability. By defining canine and feline obesity as a disease, regardless of the exact cause, we believe both veterinarians and owners will be compelled to act.  We also believe the designation as a disease will encourage the veterinary medical profession and industry to become more innovative and create solutions for this prevalent, yet often-neglected condition. 

Some have argued against obesity being classified as a disease on the basis that diagnostic criteria (such as BMI in humans and BCS in animals) are imprecise and flawed.27 They further argue that there is inconsistency in terms of when consequences of obesity are observed, such that two individuals with a similar degree of adiposity can have marked differences in comorbidities and overall health.  They argue that obesity is instead a continuum and that applying an arbitrary definition of a disease state on top of this is unhelpful.27  While we agree both that there are flaws in the methodology used to quantify fat mass and that consequences are unpredictable, we disagree that these issues invalidate the classification of obesity as a disease.  Applying defined cut-points to a continuum is common across many chronic veterinary diseases, for example, chronic kidney disease, where the staging of the International Renal Interest Society42 has received widespread acceptance.  However, while the different stages are clearly demarcated by diagnostic cut-points based on serum creatinine concentration, the presence of clinical consequences such as hypertension, proteinuria, and uremic syndrome are inconsistent and variable. Similarly, the American College of Veterinary Dentistry has defined and described a disease classification system for the highly prevalent periodontal disease where the stages of periodontitis and furcation involvement of the disease can vary between individual teeth of the same patient.43  Further, flaws in the diagnosis do not invalidate the ability of many other veterinary conditions to be called diseases.  For example, despite admirable attempts at standardization,44,45 the definition of inflammatory bowel disease remains unclear, and there is substantial inconsistency in interpretation among pathologists.46  Therefore,  to be consistent with other chronic diseases with similar characteristics, we call on global veterinary medical organizations and governing bodies to join us in the formal classification of canine and feline obesity as a disease.

References 

1.     Rolph NC, Noble PJM, German AJ.  How often do primary care veterinarians record the overweight status of dogs? J Nutr Sci 2014:3;e58.

2.     Bray GA, Kim KK, Wilding J.  Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.  Obesity Rev 2017;18:715-723.

3.     Lund EM, Armstrong PJ, Kirk CA, et al.  Prevalence and risk factors for obesity in adult cats from private US veterinary practices. Intern J Appl Res Vet Med 2005;3:88-96.

4.     Lund EM, Armstrong PJ, Kirk CA, et al. Prevalence and risk factors for obesity in adult dogs from private US veterinary practices. Int J Appl Res Vet Med 2006;4:177-186.

5.     German AJ. The growing problem of obesity in dogs and cats.  J Nutr 2006;136;1940S-1946S.

6.     German AJ, Hervera M, Hunter L, et al.  Insulin Resistance and Reduction in Plasma Inflammatory Adipokines After Weight Loss in Obese Dogs.  Domest Anim Endocrinol 2009;37:214-226.

7.     Tvarijonaviciute A, Ceron JJ, Holden SL, et al.  Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.  BMC Vet Res 2012a;8:147.

8.     Tvarijonaviciute A, Ceron JJ, Holden SL, et al. Effects of weight loss in obese cats on biochemical analytes relating to inflammation and glucose homeostasis.  Domest Anim Endocrinol 2012;42:129-141.

9.     Tvarijonaviciute A, Ceron JJ, Holden SL, et al.  Effect of weight loss in obese dogs on indicators of Renal function or disease.  J Vet Intern Med 2013;27:31-38.

10.  Mosing M, German AJ, Holden SL, et al. Oxygenation and ventilation characteristics in obese sedated dogs before and after weight loss: A clinical trial.  Vet J 2013;198:367-371 

11.  Tropf M, Nelson OL, Lee PM, Weng HY.  Cardiac and metabolic variables in obese dogs.  J Vet Intern Med 2017;31:1000-1007 

12.  German AJ, Holden SL, Wiseman-Orr, ML, et al.  Quality of life is reduced in obese dogs but improves after successful weight loss. Vet J 2012;192:428-434.

13.  Yam PS, Butowskia CF, Chitty JL, et al.  Impact of canine overweight and obesity on health-related quality of life.  Prev Vet Med 2016;127:64-69.

14.  Laflamme D. Development and validation of a body condition score system for dogs. Canine Pract 1997;22:10-15.

15.  Laflamme D. Development and validation of a body condition score system for cats. Feline Pract 1997;25:13-18 

16.  German AJ, Holden SL, Bissot T, el al. Use of Starting Condition Score to Estimate Changes in Body Weight and Composition During Weight Loss in Obese Dogs. Res Vet Sci 2009;87:249-254.

17.  Bjornvad CR, Nielsen DH, Armstrong PJ, et al. Evaluation of a nine-point body condition scoring system in physically inactive pet cats.  Am J Vet Res 2011;72:433-437.

18.  German AJ. Obesity prevention and weight management after loss. Vet Clin N Amer 2016:46:913-929. 

19.  Scarlett JM, Donoghue S. Associations between body condition and disease in cats. J Am Vet Med Assoc 1998;212:1725-1731.

20.  Witzel AL, Kirk CA, Henry GA, et al.  Use of a novel morphometric method and body fat index system for estimation of body composition in overweight and obese dogs.  J Am Vet Med Assoc 2014;244:1279-1284.

21.  Witzel AL, Kirk CA, Henry GA, et al.  Use of a morphometric method and body fat index system for estimation of body composition in overweight and obese cats.  J Am Vet Med Assoc 2014;244:1285-1290.

22.  Flanagan J, Bissot T, Hours M-A, et al. Success of a weight loss plan for overweight dogs: The results of an international weight loss study. PLoS ONE 20017;12: e0184199.

23.  WSAVA Global Nutrition Committee.  WSAVA global nutrition guidelines.  Available at: http://www.wsava.org/WSAVA/media/Documents/Guidelines/WSAVA-Global-Nutritional-Assessment-Guidelines-2011-final.pdf.  Accessed March 12, 2018.

24.  Kopelman PG. Obesity as a medical problem. Nature 2000;404: 635-643.

25.  Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease. Endocrinol Metab Clin N Am 2016;45:511–520.

26.  Bray GA, Kim KK, Wilding J.  Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.  Obesity Rev 2017;18: 15-723 

27.  Muller MJ, Geisler C.  Defining obesity as a disease.  Eur J Clin Nutr 2017;71:1256-1258.

28.  Vallgarda S, Nielsen MEJ, Hansen AKK, et al. Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument. Eur J Clin Nutr 2017;71:1263-1267.

29.  Faber K. Nosography in Modern Internal Medicine. Paul B. Hoeber, Inc.: New York, 1923.

30.  Garvey WT, Garber AJ, Mechanick JI et al., for the AACE Obesity Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on obesity: building an evidence base for comprehensive action. Endocr Pract 2014;20:956-976.

31.  Garvey WT, Mechanick JI, Brett EM et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 2016;22 (Suppl):1-203.

32.  Courcier EA, Thompson RM, Mellor DJ. An epidemiological study of environmental factors associated with canine obesity. J Small Anim Pract 2010;51:362-367.

33.  Courcier EA, O’Higgins R, Mellor DJ, et al. Prevalence and risk factors for feline obesity in a first opinion practice in Glasgow, Scotland. J Feline Med Surg 2010;12:746-753.

 34.  Brooks D, Churchill J, Fein K, et al.  2014 AAHA Weight Management Guidelines for Dogs and Cats.  J Am Anim Hosp Assoc 2014;50:1-11.

35.  BANFIELD® Pet Hospitals.  Obesity in dogs and cats – state of pet health report [cited 24 November 2017].  In: Obesity in dogs and cats – state of pet health report.  Available at: https://www.banfield.com/state-of-pet-health/obesity.  Accessed March 16, 2018.

36.  Mao J, Xia Z, Chen J, Yu J.  Prevalence and risk factors for canine obesity surveyed in veterinary practices in Beijing, China.  Prev Vet Med 2013;112:438-442.

37.  German AJ, Woods GRT, Holden SL, et al.  Dangerous trends in pet obesity.  Vet Rec 2018;182:25.

38.  Kealy RD, Lawler DF, Ballam JM, et al. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 2002:220;1315-1320.

39.  German AJ, Ryan VH, German AC, et al.  Obesity, its associated disorders and the role of inflammatory adipokines in companion animals. Vet J 2010:185:4-9. 

40.  Bomberg E, Birch L, Endenburg E, et al.  The financial costs, behaviour and psychology of obesity: a one health analysis.  J Comp Pathol 2017;156:310-325.

41.  Day MJ.  One health approach to preventing obesity in people and their pets.  J Comp Pathol 2017;156:293-295.

42.  International Renal Interest Society.  IRIS staging of CKD.  Available at: http://www.iris-kidney.com/guidelines/staging.html.  Accessed March 12, 2018.

43.  Wolf HF. Rateitschak KH et al. Color atlas of dental medicine: periodontalology, 3rd ed. Stuttgart: Georg Thieme Verlag, 2005.

44.  Day MJ, Bilzer T, Mansell J, et al.  Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group.  J Comp Pathol 2008;138:S1-S43 

45.  Day MJ, Willard MD, Hall EJ, et al.  Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals.  J Vet Intern Med 2010;24:10-16.

46.  Willard MD, Moore GE, Denton BD, et al.  Effect of tissue processing on assessment of endoscopic intestinal biopsies in dogs and cats.  J Vet Intern Med 2009;24:84-89.